Comparative Pharmacology
Head-to-head clinical analysis: DYCILL versus PENTIDS 800.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DYCILL versus PENTIDS 800.
DYCILL vs PENTIDS '800'
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Penicillin G benzathine is a slow-release parenteral formulation of penicillin G that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), inhibiting transpeptidation, and activating autolytic enzymes.
Penicillin G is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), transpeptidases that catalyze the final transpeptidation step of peptidoglycan cross-linking, leading to cell lysis.
250 mg orally every 6 hours or 500 mg orally every 12 hours.
800 mg orally every 6 to 8 hours; maximum 4 g per day.
None Documented
None Documented
0.5-1 hour; prolonged in renal impairment (up to 20 hours in severe cases).
0.5-1 hour; prolonged to 2-5 hours in renal impairment.
Renal: approx. 60-80% unchanged by glomerular filtration and tubular secretion. Biliary/fecal: minor (less than 10%).
Renal: ~60-85% unchanged via glomerular filtration and tubular secretion; Biliary: ~10%; Fecal: <5%.
Category C
Category C
Penicillin Antibiotic
Penicillin Antibiotic